In tumors associated with metabolic disorders, aerobic glycolysis-dominant PKM2 activity restricts pyruvate entry into mitochondria, suppressing oxidative phosphorylation (OXPHOS) and contributing to hepatic steatosis, which further reinforces a tumor-promoting metabolic niche (42). This evidence concerns the gene PKM and neoplasm.